Global Genome Sequencing Market Outlook and Forecast 2021-2026: The Emergence of Nanopore, Third Generation Genome Sequencing Platform – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Genome Sequencing Market – Global Outlook and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering.

The global genome sequencing market by revenue is expected to grow at a CAGR of over 9% during the period 2021-2026.

The global market is expected to grow due to the growing number of rare, terminal, and complex diseases, especially cancer. The constant increase in cancer cases is proportionately increasing the number of sequencing-based diagnostics and treatment options in the market. The introduction of single-cell sequencing technology performs advanced sequencing, thereby helping in cell mapping of tumor cells.

This technology is widely used in several tumor researches and has been significantly beneficial for developing new diagnostic and anti-tumor treatment methods. The single-cell analysis has become a standard application both in basic and translational research. This technology is widely used in the field of reproductive and embryonic medicine. It can sequence and quantify the whole genome of germ cells and embryonic cells at the single-cell level, thereby helping researchers to understand the occurrence of germ cells.

Insights by Vendors

Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, BGI, Pacific Biosciences, Oxford Nanopore Technology are the major vendors in the market.

The market is competitive and is evolving with the introduction of new technologies in the market. Several companies are developing or commercializing products, expanding their manufacturing facilities, partnering with others in the market. For instance, in 2020, Illumina introduced software for whole-genome analysis to examine rare diseases. Similarly, Thermo Fischer scientific has made a strategic partnership with First genetics JCS to promote NGS in Russia.

The Oxford Nanopore technology, nanopore-based sequencing, and Pacbio’s SMRT technology-based sequencing revolutionize genome sequencing by reducing cost and increasing throughput, attracting end-users to shift from conventional sanger methods to advanced methods in the market.

The following factors are likely to contribute to the growth of the genome sequencing market during the forecast period:

• Increase in Demand for Single Cell Sequencing
• Introduction of Portable Genome Sequencing Devices
• The emergence of Nanopore, Third Generation Genome Sequencing Platform

Key Questions Answered

• What technological advances are the genome sequencing market observing?
• What is the growth rate of the genome sequencing market during the forecast period?
• How the outbreak of the COVID-19 pandemic affect the genome sequencing market?
• Which regions are likely to hold the largest revenue share during the forecast period?
• Which end-user segment accounted for the largest market share in 2021?

Prominent Vendors

• Illumina
• Thermo Fisher Scientific
• Oxford Nanopore Technology
• Pacific Biosciences
• F. Hoffmann-La Roche
• BGI

Other Prominent Vendors

• PerkinElmer
• Siemens Healthineers
• Qiagen
• Macrogen
• Myriad
• Intrexon Bioinformatics
• Biomatters
• Cytiva
• 10x Genomics
• MGI Tech
• New England Biolabs
• DNASTAR
• Beckman Coulter
• VEROGEN
• Bio-Rad

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.2 Base Year

4.3 Scope of The Study

4.4 Market Segments

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

8 Market Opportunities & Trends

8.1 Increase In The Demand For Single-Cell Sequencing

8.2 Introduction Of Portable Genome Sequencing Devices

8.3 Emergence Of Nanopore, Third Generation Genome Sequencing Platform

9 Market Growth Enablers

9.1 Rising Patient Population

9.2 Declining Cost of Genome Sequencing

9.3 Increasing Genome Sequencing Service Providers

10 Market Restraints

10.1 Influence Of The COVID-19 Pandemic On The Genome Sequencing Market

10.2 Low Penetration Of Genome Sequencing In Developing Countries

10.3 Ethical & Regulatory Concerns Associated With Genome Sequencing

11 Market Landscape

11.1 Market Overview

11.2 Market Size & Forecast

11.3 Five Forces Analysis

12 Product

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Consumables

12.4 Sequencers & Software

13 Application

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Oncology

13.4 Reproductive Health

13.5 Complex Disease Research

13.6 Microbial Research

13.7 Others

14 End-User

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Academic & Research Institutes

14.4 Pharma & Biotechnology Companies

14.5 Consumer Genomic Service Providers

14.6 Government and Commercial Labs

14.7 Others

15 Geography

15.1 Market Snapshot & Growth Engine

15.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/nsthol

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900